By: Benzinga
January 18, 2013 at 17:01 PM EST
BOTOX Wins FDA Approval for Treatment of Overactive Bladder for Adults
Allergan, Inc. (NYSE: AGN ) announced today that the U.S. Food and Drug Administration (FDA) has approved BOTOX^® (onabotulinumtoxinA) for the treatment of overactive bladder (OAB) with symptoms of urge urinary incontinence, urgency and frequency in adults who have had an inadequate response to or are intolerant of an anticholinergic medication. In two double-blind,
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here